Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women

This publication has 34 references indexed in Scilit:

• Reduced, Oxidized and Protein-Bound Forms of Homocysteine and Other Aminothiols in Plasma Comprise the Redox Thiol Status—A Possible Element of the Extracellular Antioxidant Defense System
  The Journal of Nutrition, 1996
• Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
  New England Journal of Medicine, 1996
• Coexistence of Hereditary Homocystinuria and Factor V Leiden — Effect on Thrombosis
  New England Journal of Medicine, 1996
• Vitamin Requirements for the Treatment of Hyperhomocysteinemia in Humans
  The Journal of Nutrition, 1994
• Sulfhydryl compounds influence immunoreactivity, structure and functional aspects of lipoprotein (a)
  Thrombosis Research, 1994
• Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.
  Proceedings of the National Academy of Sciences, 1992
• Endothelium-Derived Relaxing Factor Modulates the Atherothrombogenic Effects of Homocysteine
  Journal of Cardiovascular Pharmacology, 1992
• Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors
  European Journal of Clinical Investigation, 1992
• Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
  Stroke, 1990
• Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
  Journal of Clinical Investigation, 1986